Investigational Drug Information for D-glucose
✉ Email this page to a colleague
What is the development status for investigational drug D-glucose?
D-glucose is an investigational drug.
There have been 48 clinical trials for D-glucose.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2021.
The most common disease conditions in clinical trials are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, and Carcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), University of Pennsylvania, and M.D. Anderson Cancer Center.
There are thirteen US patents protecting this investigational drug and six hundred and fifty-one international patents.
Summary for D-glucose
| US Patents | 13 |
| International Patents | 651 |
| US Patent Applications | 72 |
| WIPO Patent Applications | 25 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2021-06-01) |
| Vendors | 34 |
Recent Clinical Trials for D-glucose
| Title | Sponsor | Phase |
|---|---|---|
| Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial | ECOG-ACRIN Cancer Research Group | Phase 2 |
| A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab | National Cancer Institute (NCI) | Phase 3 |
| Pancreatic Clamp in NAFLD | Albert Einstein College of Medicine | Phase 1 |
Clinical Trial Summary for D-glucose
Top disease conditions for D-glucose
Top clinical trial sponsors for D-glucose
US Patents for D-glucose
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| D-glucose | ⤷ Try a Trial | Cancerous B cell treatment using substituted nucleoside derivatives | The Scripps Research Institute (La Jolla, CA) | ⤷ Try a Trial |
| D-glucose | ⤷ Try a Trial | Adhesive base material | Kowa Co., Ltd. (Nagoya, JP) | ⤷ Try a Trial |
| D-glucose | ⤷ Try a Trial | Purified mite allergen | Fumakilla Ltd. (Tokyo, JP) Hiroshima University (Hiroshima-Ken, JP) | ⤷ Try a Trial |
| D-glucose | ⤷ Try a Trial | Positive selection | Novartis AG (Basel, CH) | ⤷ Try a Trial |
| D-glucose | ⤷ Try a Trial | Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury | Cardax Pharmaceuticals, Inc. (Aiea, HI) | ⤷ Try a Trial |
| D-glucose | ⤷ Try a Trial | Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease | Cardax Pharmaceuticals, Inc. (Aiea, HI) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for D-glucose
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| D-glucose | Australia | AU598213 | 2005-12-06 | ⤷ Try a Trial |
| D-glucose | Australia | AU6613986 | 2005-12-06 | ⤷ Try a Trial |
| D-glucose | Denmark | DK586286 | 2005-12-06 | ⤷ Try a Trial |
| D-glucose | European Patent Office | EP0225292 | 2005-12-06 | ⤷ Try a Trial |
| D-glucose | Israel | IL80891 | 2005-12-06 | ⤷ Try a Trial |
| D-glucose | Japan | JPS62145051 | 2005-12-06 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
